trial · primary record
LND101
Non Small Cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 160 |
| Primary completion | 2031-06-30 |
| Primary endpoint | Progression Free Survival based on RECIST 1.1 criteria |
| Registry ID | NCT07890493 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:10.884Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07890493
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.